Key companies covered in spirulina market are Fraken Biochem Co., Ltd. Dongtai City Spirulina Bio-engineering Co. Algenol Biofuels Inc. DIC Corporation Parry Nutraceuticals Ltd. Chr. Hansen Holding A/S Fuqing King Dnarmsa Spirulina Co., Ltd. Prolgae Spirulina Supplies Pvt. Ltd. Naturex S.A. Cyanotech Corporation Sensient Technologies Corporation and more players profiled.

Pune, India, Feb. 15, 2022 (GLOBE NEWSWIRE) -- The global spirulina market size is projected to expand speedily owing to the potential benefits of spirulina for COVID-19 patients, finds Fortune Business Insights™ in its report, titled “Spirulina Market, 2022-2029”.

A study published in the journal ‘Marine Biotechnology’ in February 2021 by scientists from Israel and Iceland propounds that extracts from blue-green algae can prevent COVID-19 patients from getting seriously ill. According to the scientists, a derivative of enhanced spirulina can reduce the probability of the cytokine storm triggered by the coronavirus in the lungs, which can cause acute respiratory distress, by 70%. This is possible because the extract from this alga contains a pigment-binding protein that augments anti-inflammation, anti-tumor, and anti-oxidation activities in the body.

Another study, conducted in June 2020 by researchers from the Indian Institute of Science Education and Research (IISER), found that spirulina extracts can potentially inhibit the entry of SARS, MERS, and SARS-2 spike pseudotyped virus in vitro. Thus, the coronavirus outbreak is likely to boost the adoption of natural algae extracts and brighten the outlook of this market.

Get a Sample PDF Brochure:

https://www.fortunebusinessinsights.com/enquiry/request-sample-pdf/spirulina-market-102479

List of Key Players Covered in the Spirulina Market Report:

Dongtai City Spirulina Bio-engineering Co.

Chr. Hansen Holding A/S

Fuqing King Dnarmsa Spirulina Co., Ltd.

Prolgae Spirulina Supplies Pvt. Ltd.

What Does the Report Offer?

The report offers an accurate computation of market figures and supplies a comprehensive analysis of the factors, trends, and restraints shaping the size, share, and growth of the market. In addition, the report encapsulates a careful study of market segments and provides a detailed examination of the regional dynamics and competitive milieu of the market.

In terms of type, the market has been segmented into:

Based on form, the market has been divided into:

By application, the market has been clubbed into:

On the basis of region, the market has been analyzed across:

Browse Detailed Summary of Research Report with TOC:

https://www.fortunebusinessinsights.com/spirulina-market-102479

Spirulina-based Innovations by Startups to Drive Market

The emergence of startups in the algae-based foods domain is driving innovation and fueling the spirulina market growth. These startups are focused on developing algae-based food items, with an aim to cater to the demands of the growing vegan population. For example, in February 2019, Prolgae, a startup based in India, created vegan chocolate bars and cookies formulated from spirulina and its extracts. Furthermore, this species of algae is also seen as a potential instrument against malnutrition, according to the Food and Agriculture Organization (FAO), prompting a few companies to produce algae-based food items and make them accessible to all. In October 2018, for instance, Proalgae announced its plans to produce high-quality, sun-dried spirulina to fight malnutrition in India and Africa. Some other startups intend to popularize this alga’s super-food status. For example, SNACK Brand, a startup launched in January 2021, will be developing farm-fresh versions of this alga in the form of clusters and powders and combine them nutrient-dense ingredients, such as flax seeds and dry fruits.

Widespread Production of Spirulina to Propel the Asia Pacific Market Growth

Asia Pacific is anticipated to command the spirulina market share during the forecast period owing to the high production of the algae in Korea, China, and Indonesia. The increasing blending of this algal species with nutraceuticals in non-dairy products is expected to further support the regional market growth. The market in Europe will be majorly driven by the soaring demand for natural food colors in the continent. In countries such as France and the UK, the rising adoption of veganism and growing demand for natural, nutrient-rich ingredients in the food industry will also aid the regional market. Similar trends are foreseen in North America as well, where the preference for clean-label food and beverage products is steadily increasing.

Advancements in Food Formulation Technologies to Energize the Market

The dynamics of this market are being steered and shaped by the sophistication in food formulation technologies heralded by research institutions and private companies. The advent of spirulina in the food industry has opened multiple avenues of innovation in this market and key players are tapping these opportunities by stepping up their investments in research & development activities, thereby cementing their position in the market.

Inquire Before Buying This Research Report:

https://www.fortunebusinessinsights.com/enquiry/queries/spirulina-market-102479

August 2019: ScotBio announced the development of a novel technique of augmenting the amount of phycocyanin, the blue pigment found in spirulina algae. According to the company, the innovation will allow indoor-cultivated varieties of this alga a cost-effective option for food companies.

Fortune Business Insights™ delivers accurate data and innovative corporate analysis, helping organizations of all sizes make appropriate decisions. We tailor novel solutions for our clients, assisting them to address various challenges distinct to their businesses. Our aim is to empower them with holistic market intelligence, providing a granular overview of the market they are operating in.

Fortune Business Insights Pvt. Ltd.

Baner - Mahalunge Road, Baner,

Connect us via Social Media Channels:

One day after Boeing (NYSE: BA) stock bounced higher on news of a big 737 plane sale to the parent company of British Airways and Iberia (the International Consolidated Airlines Group), shares of the airplane-building juggernaut are falling 7.2% as of 1:10 p.m. ET. The reason: Boeing may be encountering turbulence at higher altitudes. Earlier on Thursday, the big news around Boeing was the company's announcement that International Airlines Group has agreed to buy 25 Boeing 737-8-200 aircraft and 25 737 MAX 10 jetliners -- and taken out an option to buy as many as 100 more planes besides.

Shares of the artificial intelligence lender Upstart Holdings (NASDAQ: UPST) traded more than 16% lower as of 11:14 a.m. ET today after it received yet another downgrade from Wall Street. Wedbush analyst David Chiaverini maintained his underperform rating on Upstart but lowered his price target from $20 to $15 per share. The lower price target comes just a week after Chiaverini lowered his price target on Upstart from $35 to $20.

Over the past month, the odds of a home price correction spiked. That's according to an analysis CoreLogic ran for Fortune this week.

When Berkshire Hathaway (NYSE: BRK.A)(NYSE: BRK.B) CEO Warren Buffett buys or sells shares of a company, Wall Street and investors tend to pay close attention. Since becoming CEO in 1965, he's overseen the creation of more than $680 billion in shareholder value and delivered an average annual return of 20.1% for Berkshire's Class A (BRK.A) shareholders (himself included).

Yahoo Finance Live anchors discuss allegations that Elon Musk sexually harassed a flight attendant in 2016.

Shares of Pfizer (NYSE: PFE) were up 2.5% as of 11:35 a.m. ET on Friday after jumping as much as 4% earlier in the day. Meanwhile, the stocks of two other COVID-19 vaccine makers were declining. Moderna's (NASDAQ: MRNA) shares were down 4.7%.

Cathie Wood is a long-time Tesla bull, but the stock isn't the largest holding in Wood's ARK Innovation ETF anymore.

What happened The ride in Ford (NYSE: F) stock wasn't very smooth on Friday. The big American carmaker saw its shares decline by nearly 3% on a day when the S&P 500 index essentially traded sideways. A ruling from a court overseas was the key catalyst in that deceleration.

Yahoo Finance Live anchors discuss second-quarter earnings for Deere.

Athersys Inc's (NASDAQ: ATHX) partner, Healios K.K. has reported topline results for its Japan ischemic stroke study, TREASURE. The study included patients with moderate to moderate-severe ischemic stroke administered a single dose of MultiStem cells (invimestrocel) or placebo by intravenous infusion within 18-36 hours of the event. The primary endpoint, Excellent Outcome at 90 days, did not reach statistical significance in this population. Overall, consistent improvement in essentially all mea

In this article, we discuss 6 stocks that Warren Buffett is selling in 2022. If you want to see more stocks that the billionaire sold, click Warren Buffett is Selling These 3 Stocks in 2022. Warren Buffett, the chief of Berkshire Hathaway, is perhaps the most renowned financier in the investment world, with decades of […]

Shares of Nvidia (NASDAQ: NVDA) continued to tumble on Friday, falling as much as 8%. Wells Fargo analyst Aaron Rakers lowered his price target on Nvidia to $250, down from $370, while maintaining his overweight (buy) rating on the stock, according to The Fly.

Nio (NYSE: NIO) shares began trading on the main board of the Singapore stock exchange today prior to the opening of the U.S. markets. After initially popping 20% early, the new shares ended up closing in Singapore about 2.4% higher, according to Barron's.

In less than week -- Wednesday, May 25 -- Nvidia (NVDA) is due to report its Q1 2022 earnings. Analysts on average are optimistic about the report itself, and also about the guidance Nvidia might give, predicting Nvidia will report 43% growth to $1.30 per share this quarter, and promise investors another 31% worth of growth ($1.36 per share) next quarter. And one analyst thinks Nvidia could do even better than that. Previewing next Wednesday's earnings report, Oppenheimer's Rick Schafer reiterat

(Bloomberg) -- It’s been hard to watch, impossible to predict and a nightmare to trade. But has the S&P 500’s slide been an unqualified panic to date? By some measures no, and that might bode poorly for equities in the near term. Most Read from BloombergOne of the World’s Frothiest Housing Markets Turned Into a Seller’s Headache OvernightElon Musk Gets Defensive Over Twitter Meme as Harassment Report SurfacesStocks Avert Bear Market, Slide for Seventh Week: Markets WrapApple Shows AR/VR Headset

Rising interest rates, supply chain constraints and Russia’s invasion of Ukraine are all issues currently plaguing the macro climate. The problem with all three, says Tony Dwyer, Canaccord Chief Market Strategist, is that for each problem there’s “no easy exit strategy.” The tough conditions are likely to persist, then. However, on the plus side, while these issues have sent most corners of the stock market into a tailspin, now investors are presented with stocks for which the term “oversold” re

In early trading Friday, stock markets attempted to make a comeback and at least end a losing week on a winning note. As of 12:25 p.m. ET, shares of Rivian Automotive (NASDAQ: RIVN) are off 4.9%, Nikola (NASDAQ: NKLA) stock is down 5.8%, and Lucid Group (NASDAQ: LCID) -- the beneficiary of positive news as recently as yesterday -- is giving back most of its gains, and leading the sector 6.8% lower today.

The veteran tech giant just completed a multi-year turnaround. Here's the investment opportunity with the new IBM.

High-yield dividend stocks have been viewed more favorably than high-multiple growth stocks these days. After yet another month of excessive market-wide selling, the yields of many top dividend stocks are slightly richer. As the Fed raises interest rates further, growth and value could continue to get slammed. This week, the Fed signaled that it's more than willing to keep the rate hikes coming until inflation backs down, even if it means jeopardizing a "soft landing" and inflicting more pain in

A bear market for the S&P 500? The stage certainly appears to be set for one, as equity benchmarks added to ugly weekly declines on Friday.